Healthcare -
Biotechnology - NASDAQ - US
$ 1.6
1.3 %
$ 1.02 B
Market Cap
-7.43
P/E
GERN - OPERATING EXPENSES
Operating Expenses GERN - Geron Corporation
249 M
LAST VALUE
33.90%
2 YEAR CAGR
27.87%
5 YEAR CAGR
20.88%
10 YEAR CAGR